Atherosclerotic Renal Artery Stenosis: Review of Pathophysiology, Clinical Trial Evidence, and Management Strategies

Canadian Journal of Cardiology

Volumn 27, Issue 4, 2011, Pages 468-480

  Seddon, Michael ^a   Saw, Jacqueline ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; DOPPLER ECHOGRAPHY; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE OVERLOAD; HUMAN; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; LUNG EDEMA; MAGNETIC RESONANCE ANGIOGRAPHY; MALIGNANT HYPERTENSION; NEPHROSCLEROSIS; PATHOPHYSIOLOGY; PATIENT SELECTION; PREVALENCE; RENAL REPLACEMENT THERAPY; REVASCULARIZATION; REVIEW; TREATMENT INDICATION;

ANGIOPLASTY; ARTERIOSCLEROSIS; CLINICAL TRIALS AS TOPIC; HUMANS; RENAL ARTERY OBSTRUCTION; VASCULAR SURGICAL PROCEDURES;

EID: 80052421535     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2010.12.038     Document Type: Review

References (120)

1. Rundback J.H., Sacks D., Kent K.C., et al. American Heart Association. Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation 2002, 106:1572-1585.
2. Slovut D.P., Olin J.W. Fibromuscular dysplasia. N Engl J Med 2004, 350:1862-1871.
3. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113:e463-e654.
4. Derkx F.H., Schalekamp M.A. Renal artery stenosis and hypertension. Lancet 1994, 344:237-239.
5. Hansen K.J., Edwards M.S., Craven T.E., et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002, 36:443-451.
6. Rimmer J.M., Gennari F.J. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993, 118:712-719.
7. Aqel R.A., Zoghbi G.J., Baldwin S.A., et al. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J Hypertens 2003, 21:1157-1162.
8. Weber-Mzell D., Kotanko P., Schumacher M., Klein W., Skrabal F. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J 2002, 23:1684-1691.
9. Harding M.B., Smith L.R., Himmelstein S.I., et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992, 2:1608-1616.
10. Zoccali C., Mallamaci F., Finocchiaro P. Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. J Am Soc Nephrol 2002, 13(suppl 3):S179-S183.
11. Olin J.W., Melia M., Young J.R., Graor R.A., Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990, 88(1N):46N-51N.
12. Schwartz C.J., White T.A. Stenosis of renal artery: an unselected necropsy study. Br Med J 1964, 2:1415-1421.
13. Valentine R.J., Myers S.I., Miller G.L., Lopez M.A., Clagett G.P. Detection of unsuspected renal artery stenoses in patients with abdominal aortic aneurysms: refined indications for preoperative aortography. Ann Vasc Surg 1993, 7:220-224.
14. Garovic V., Textor S.C. Renovascular hypertension: current concepts. Semin Nephrol 2005, 25:261-271.
15. Garovic V.D., Textor S.C. Renovascular hypertension and ischemic nephropathy. Circulation 2005, 112:1362-1374.
16. Conlon P.J., Little M.A., Pieper K., Mark D.B. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001, 60:1490-1497.
17. Schreiber M.J., Pohl M.A., Novick A.C. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984, 11:383-392.
18. Caps M.T., Perissinotto C., Zierler R.E., et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998, 98:2866-2872.
19. Wollenweber J., Sheps S.G., Davis G.D. Clinical course of atherosclerotic renovascular disease. Am J Cardiol 1968, 21:60-71.
20. Meaney T.F., Dustan H.P., McCormack L.J. Natural history of renal arterial disease. Radiology 1968, 91:881-887.
21. Tollefson D.F., Ernst C.B. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 1991, 14:327-331.
22. Crowley J.J., Santos R.M., Peter R.H., et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 1998, 136:913-918.
23. Guzman R.P., Zierler R.E., Isaacson J.A., Bergelin R.O., Strandness D.E. Renal atrophy and arterial stenosis. A prospective study with duplex ultrasound. Hypertension 1994, 23:346-350.
24. Caps M.T., Zierler R.E., Polissar N.L., et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998, 53:735-742.
25. Mailloux L.U., Napolitano B., Bellucci A.G., et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994, 24:622-629.
26. Eggers P.W., Connerton R., McMullan M. The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival. Health Care Financ Rev 1984, 5:69-88.
27. Dorros G., Jaff M., Mathiak L., et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998, 98:642-647.
28. Kalra P.A., Chrysochou C., Green D., et al. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv 2010, 75:1-10.
29. Goldblatt H., Lynch J., Hanzal R.F., Summerville W.W. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934, 59:347-379.
30. Kim S., Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000, 52:11-34.
31. Vensel L.A., Devereux R.B., Pickering T.G., et al. Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis. Am J Cardiol 1986, 58:575-582.
32. Liard J.F., Cowley A.W., McCaa R.E., McCaa C.S., Guyton A.C. Renin, aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Goldblatt hypertension in conscious dogs. Circ Res 1974, 34:549-560.
33. Bianchi G., Campolo L., Vegeto A., Pietra V., Piazza U. The value of plasma renin concentration per se, and in relation to plasma and extracellular fluid volume in diagnosis and prognosis of human renovascular hypertension. Clin Sci 1970, 39:559-576.
34. Johansson M., Elam M., Rundqvist B., et al. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999, 99:2537-2542.
35. Petersson M.J., Rundqvist B., Johansson M., et al. Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens 2002, 20:1181-1187.
36. Higashi Y., Sasaki S., Nakagawa K., et al. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002, 346:1954-1962.
37. Korner P.I. Cardiovascular hypertrophy and hypertension: causes and consequences. Blood Press Suppl 1995, 2:6-16.
38. Epstein F.H. Oxygen and renal metabolism. Kidney Int 1997, 51:381-385.
39. Persson P.B., Ehmke H., Kirchheim H.R., et al. Autoregulation and non-homeostatic behaviour of renal blood flow in conscious dogs. J Physiol 1993, 462:261-273.
40. Textor S.C., Wilcox C.S. Ischemic nephropathy/azotemic renovascular disease. Semin Nephrol 2000, 20:489-502.
41. Dean R.H., Tribble R.W., Hansen K.J., et al. Evolution of renal insufficiency in ischemic nephropathy. Ann Surg 1991, 213:446-455. discussion 455-6.
42. Textor S.C., Wilcox C.S. Renal artery stenosis: a common, treatable cause of renal failure?. Annu Rev Med 2001, 52:421-442.
43. Imanishi M., Akabane S., Takamiya M., et al. Critical degree of renal arterial stenosis that causes hypertension in dogs. Angiology 1992, 43:833-842.
44. Wright J.R., Shurrab A.E., Cheung C., et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 2002, 39:1153-1161.
45. Suresh M., Laboi P., Mamtora H., Kalra P.A. Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant 2000, 15:631-636.
46. Textor S.C. Pathophysiology of renal failure in renovascular disease. Am J Kidney Dis 1994, 24:642-651.
47. Azizi M., Lavergne T., Day M., Pauly-Laubry C., Plouin P.F. Renal artery stenosis and congestive heart failure. Lancet 1993, 342:302.
48. Missouris C.G., Buckenham T., Vallance P.J., MacGregor G.A. Renal artery stenosis masquerading as congestive heart failure. Lancet 1993, 341:1521-1522.
49. Meyrier A. [Vascular mechanisms of renal fibrosis. Vasculonephropathies and arterial hypertension]. Bull Acad Natl Med 1999, 183:33-45. discussion 45-6.
50. Lonn E.M., Yusuf S., Jha P., et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994, 90:2056-2069.
51. Nakashima H., Suzuki H., Ohtsu H., et al. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol 2006, 4:67-78.
52. Vasan R.S., Evans J.C., Benjamin E.J., et al. Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 2004, 43:957-962.
53. Volpe M., Camargo M.J., Mueller F.B., et al. Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats. Hypertension 1990, 15:318-326.
54. Missouris C.G., Belli A.M., MacGregor G.A. "Apparent" heart failure: a syndrome caused by renal artery stenoses. Heart 2000, 83:152-155.
55. Rocha-Singh K.J., Eisenhauer A.C., Textor S.C., et al. Atherosclerotic Peripheral Vascular Disease Symposium II: intervention for renal artery disease. Circulation 2008, 118:2873-2878.
56. Olin J.W., Piedmonte M.R., Young J.R., et al. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995, 122:833-838.
57. Bolduc J.P., Oliva V.L., Therasse E., et al. Diagnosis and treatment of renovascular hypertension: a cost-benefit analysis. AJR Am J Roentgenol 2005, 184:931-937.
58. Baumgartner I., Behrendt P., Rohner P., Baumgartner R.W. A validation study on the intraobserver and interobserver reproducibility of renal artery duplex ultrasound. Ultrasound Med Biol 1999, 25:225-231.
59. Radermacher J., Chavan A., Schaffer J., et al. Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure. Clin Nephrol 2000, 53:333-343.
60. Soares G.M., Murphy T.P., Singha M.S., Parada A., Jaff M. Renal artery duplex ultrasonography as a screening and surveillance tool to detect renal artery stenosis: a comparison with current reference standard imaging. J Ultrasound Med 2006, 25:293-298.
61. Williams G.J., Macaskill P., Chan S.F., et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol 2007, 188:798-811.
62. Vasbinder G.B., Nelemans P.J., Kessels A.G., et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004, 141:674-682. discussion 682.
63. Prchal D., Holmes D.T., Levin A. Nephrogenic systemic fibrosis: the story unfolds. Kidney Int 2008, 73:1335-1337.
64. Urban B.A., Ratner L.E., Fishman E.K. Three-dimensional volume-rendered CT angiography of the renal arteries and veins: normal anatomy, variants, and clinical applications. Radiographics 2001, 21:373-386. questionnaire 549-55.
65. Willmann J.K., Wildermuth S., Pfammatter T., et al. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology 2003, 226:798-811.
66. Kawashima A., Sandler C.M., Ernst R.D., et al. CT evaluation of renovascular disease. Radiographics 2000, 20:1321-1340.
67. Textor S.C., Glockner J.F., Lerman L.O., et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 2008, 19:780-788.
68. Rihal C.S., Textor S.C., Breen J.F., et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc 2002, 77:309-316.
69. Plouin P.F., Chatellier G., Darne B., Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998, 31:823-829.
70. Webster J., Marshall F., Abdalla M., et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998, 12:329-335.
71. Nordmann A.J., Woo K., Parkes R., Logan A.G. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis?. A meta-analysis of randomized controlled trials. Am J Med 2003, 114:44-50.
72. Tullis M.J., Caps M.T., Zierler R.E., et al. Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis. Am J Kidney Dis 1999, 33:675-681.
73. Losito A., Gaburri M., Errico R., Parente B., Cao P.G. Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol 1999, 52:339-343.
74. Losito A., Errico R., Santirosi P., et al. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant 2005, 20:1604-1609.
75. Hackam D.G., Duong-Hua M.L., Mamdani M., et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 2008, 156:549-555.
76. van de Ven P.J., Beutler J.J., Kaatee R., et al. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int 1998, 53:986-993.
77. Cheung C.M., Patel A., Shaheen N., et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract 2007, 107:c35-c42.
78. Khong T.K., Missouris C.G., Belli A.M., MacGregor G.A. Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy. J Hum Hypertens 2001, 15:431-433.
79. Silva V.S., Martin L.C., Franco R.J., et al. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am J Hypertens 2008, 21:1163-1168.
80. Chade A.R., Zhu X.Y., Grande J.P., et al. Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens 2008, 26:1651-1660.
81. Safian R.D., Madder R.D. Refining the approach to renal artery revascularization. JACC Cardiovasc Interv 2009, 2:161-174.
82. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
83. Radermacher J., Chavan A., Bleck J., et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001, 344:410-417.
84. Zeller T., Muller C., Frank U., et al. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Catheter Cardiovasc Interv 2003, 58:510-515.
85. Colyer W.R., Cooper C.J., Burket M.W., Thomas W.J. Utility of a 0.014" pressure-sensing guidewire to assess renal artery translesional systolic pressure gradients. Catheter Cardiovasc Interv 2003, 59:372-377.
86. Leesar M.A. Baseline fractional flow reserve and stent diameter predict event rates after stenting: a further step, but still much to learn. JACC Cardiovasc Interv 2009, 2:364-365.
87. Mitchell J.A., Subramanian R., White C.J., et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement: renal fractional flow reserve. Catheter Cardiovasc Interv 2007, 69:685-689.
88. de Bruyne B., Manoharan G., Pijls NH V., et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 2006, 48:1851-1855.
89. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991, 87:1402-1412.
90. Lai K.N., Leung J.C., Yandle T.G., Fisher S., Nicholls M.G. Gene expression and synthesis of natriuretic peptides by cultured human glomerular cells. J Hypertens 1999, 17:575-583.
91. Wiese S., Breyer T., Dragu A., et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 2000, 102:3074-3079.
92. Silva J.A., Chan A.W., White C.J., et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 2005, 111:328-333.
93. Mahmud E., Smith T.W., Palakodeti V., et al. Renal frame count and renal blush grade: quantitative measures that predict the success of renal stenting in hypertensive patients with renal artery stenosis. JACC Cardiovasc Interv 2008, 1:286-292.
94. Beck A.W., Nolan B.W., De Martino R., et al. Predicting blood pressure response after renal artery stenting. J Vasc Surg 2010, 51:380-385. discussion 385.
95. Textor S.C. Atherosclerotic renal artery stenosis: overtreated but underrated?. J Am Soc Nephrol 2008, 19:656-659.
96. Murphy T.P., Soares G., Kim M. Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996-2000. AJR Am J Roentgenol 2004, 183:561-568.
97. Weibull H., Bergqvist D., Bergentz S.E., et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 1993, 18:841-850. discussion 850-2.
98. Xue F., Bettmann M.A., Langdon D.R., Wivell W.A. Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting. Radiology 1999, 212:378-384.
99. White C.J., Ramee S.R., Collins T.J., et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol 1997, 30:1445-1450.
100. Lederman R.J., Mendelsohn F.O., Santos R., et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001, 142:314-323.
101. Dorros G., Prince C., Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn 1993, 29:191-198.
102. Leertouwer T.C., Gussenhoven E.J., Bosch J.L., et al. Stent placement for renal arterial stenosis: where do we stand?. A meta-analysis. Radiology 2000, 216:78-85.
103. van Jaarsveld B.C., Krijnen P., Pieterman H. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000, 342:1007-1014. Det al.
104. Harden P.N., MacLeod M.J., Rodger R.S., et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997, 349:1133-1136.
105. Watson P.S., Hadjipetrou P., Cox S.V., Piemonte T.C., Eisenhauer A.C. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000, 102:1671-1677.
106. Holden A., Hill A., Jaff M.R., Pilmore H. Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int 2006, 70:948-955.
107. Muray S., Martin M., Amoedo M.L., et al. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis 2002, 39:60-66.
108. Leertouwer T.C., Derkx F.H., Pattynama P.M., et al. Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int 2002, 62:574-579.
109. Rivolta R., Bazzi C., Stradiotti P., Paparella M. Stenting of renal artery stenosis: is it beneficial in chronic renal failure?. J Nephrol 2005, 18:749-754.
110. La Batide-Alanore A., Azizi M., Froissart M., Raynaud A., Plouin P.F. Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol 2001, 12:1235-1241.
111. Zeller T., Frank U., Muller C., et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003, 108:2244-2249.
112. Bax L., Woittiez A.J., Kouwenberg H.J., et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009, 150:840-848. W150-W1.
113. Wheatley K., Ives N., Gray R., et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009, 361:1953-1962.
114. Schwarzwalder U., Hauk M., Zeller T. RADAR: A randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials 2009, 10:60.
115. Khosla S., White C.J., Collins T.J., et al. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. Am J Cardiol 1997, 80:363-366.
116. Gray B.H., Olin J.W., Childs M.B., Sullivan T.M., Bacharach J.M. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med 2002, 7:275-279.
117. Kane G.C., Xu N., Mistrik E., et al. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant 2010, 25:813-820.
118. Hunt J.C., Sheps S.G., Harrison E.G., Strong C.G., Bernatz P.E. Renal and renovascular hypertension. A reasoned approach to diagnosis and management. Arch Intern Med 1974, 133:988-999.
119. Pizzolo F., Mansueto G., Minniti S., et al. Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. J Vasc Surg 2004, 39:140-147.
120. Cooper C.J., Murphy T.P., Matsumoto A., et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006, 152:59-66.